Viewing Study NCT04923932


Ignite Creation Date: 2025-12-24 @ 9:44 PM
Ignite Modification Date: 2026-02-03 @ 4:31 AM
Study NCT ID: NCT04923932
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-05-23
First Post: 2021-05-30
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Savolitinib for Treating Gastric Cancer and Esophagogastric Junction Adenocarcinoma Patients
Sponsor: Hutchison Medipharma Limited
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Gastric Cancer View
None Esophagogastric Junction Disorder View
Keywords: